A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy
1. Patient must have histologically confirmed ductal carcinoma in situ (DCIS) in a single breast (presence of lobular carcinoma in situ (LCIS) or other benign breast disease in addition to DCIS is acceptable) 2. Patient must have the DCISionRT™ Test ordered during routine patient care 3. Patient must be planning to undergo breast conserving surgery 4. Patient must be eligible to receive radiation and/or systemic treatment 5. Patient must be greater than 25 years old 6. Patient must have been diagnosed with DCIS within 120 days of consent 7. Patient must be able to provide informed consent
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Memorial Hospital Central
Memorial Hospital North
Protocol Number: 20-1420
More information available at ClinicalTrials.gov: NCT03448926
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers